Shorter radiation for recurrent glioblastoma
Part of Cancer clinical trials.
This trial tests a new, shorter course of radiation therapy (called hypofractionation) for people with glioblastoma that has come back. It is for patients who have already had radiation and are doing well enough to consider another round.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of glioblastoma (a type of brain tumor) or gliosarcoma, or a lower-grade tumor that turned into a grade 4 tumor.
- You must be 18 years or older.
- You must be able to do most of your daily activities on your own (Karnofsky performance score of 70% or higher).
- You must have had radiation therapy to your brain before (at full doses).
- You must have an MRI that shows the new radiation plan is safe.
- You must have enough blood cells (neutrophils and platelets) and good kidney and liver function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a two-step treatment for newly diagnosed high-grade glioma: first laser treatment (LITT) to target the tumor, followed by a shorter, more focused course of radiation. It may help shrink or control the tumor while limiting treatment time.
This trial tests a shorter course of radiation (hypofractionated RT) for people with a specific type of aggressive brain tumor (GBM) that is not suitable for surgery. It aims to see if this shorter treatment can be effective with fewer side effects.
This trial tests a combination of low-dose radiation, an immunotherapy drug (sintilimab), and chemotherapy (temozolomide) for people with glioblastoma that has come back. The goal is to see if this approach can help control the tumor and improve survival.
This trial tests a combination of immunotherapy (retifanlimab), a targeted drug (bevacizumab), and low-dose radiation for people whose glioblastoma has come back. The goal is to see if this treatment can help shrink or slow the tumor.
This trial tests a new way to deliver radiation therapy for people whose brain tumor (glioma) has come back after earlier treatment. Instead of standard radiation, it uses very low doses given in pulses, which may be safer for patients who have already had radiation to the head.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
Hear when a new Astrocytoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.